Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Return on Equity (2016 - 2025)

Historic Return on Equity for Perspective Therapeutics (CATX) over the last 14 years, with Q3 2025 value amounting to 0.0%.

  • Perspective Therapeutics' Return on Equity rose 200.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.01% for FY2024, which is 1300.0% up from last year.
  • Perspective Therapeutics' Return on Equity amounted to 0.0% in Q3 2025, which was up 200.0% from 0.0% recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Return on Equity registered a high of 0.0% during Q3 2025, and its lowest value of 0.17% during Q4 2022.
  • Its 5-year average for Return on Equity is 0.06%, with a median of 0.05% in 2024.
  • As far as peak fluctuations go, Perspective Therapeutics' Return on Equity surged by 5800bps in 2021, and later crashed by -1200bps in 2022.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Return on Equity stood at 0.05% in 2021, then tumbled by -249bps to 0.17% in 2022, then surged by 40bps to 0.1% in 2023, then skyrocketed by 97bps to 0.0% in 2024, then skyrocketed by 166bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q3 2025, 0.0% for Q2 2025, and 0.0% during Q1 2025.